Page 5 - Best Stomach cancer doctors: TOP 144 doctors

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Joseba Rebollo Liceaga brings 36 years of experience of dedicated experience in medical oncology, specializing in stomach cancer at Quirónsalud Alicante.

• Former Head of Oncology at Clínica San Miguel de Navarra and Hospital General de Villalba
• Residency and specialist training at Clínica Universidad de Navarra
• Authored research on electrochemotherapy and multidisciplinary cancer treatments
• Completed multiple advanced courses in Multidisciplinary Oncology

Specializes in gastric cancer and oncological surgery, offering targeted treatments at Büyük Anadolu Hospitals.

• Expert in pancreatic and bile duct surgeries
• Performs bariatric and metabolic surgeries
• Skilled in colon and thyroid cancer procedures

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

15,000+ surgical procedures performed – Dr. de Lacy is a pioneer in minimally invasive gastrointestinal surgery at Hospital Quiron Barcelona.

• Performs 1,000+ interventions annually using laparoscopic and robotic techniques
• World's first to remove gallbladder through the mouth – patients discharged in days
• Founder of TaTME technique for rectal cancer surgery
• President of the Association of Surgeons-Endoscopists in Europe

Dr. Leng Yin specializes in treating cancers of the liver, gallbladder, stomach, pancreas, and intestines at Fuda Cancer Hospital.

• Experienced oncologist with work at Bumrungrad International and Royal Siriraj Hospitals
• Member of The Chinese Anti-Cancer Association
• Expertise in both diagnosis and treatment of gastrointestinal cancers

Head of Radiation Oncology at Samsung Medical Center, Prof. Lim specializes in stomach cancer treatment with a focus on precise radiation therapy.

• Trained at Seoul National University Hospital and Samsung Medical Center
• Specializes in stomach, pancreaticobiliary, and CNS tumors
• Leads a top-tier radiation oncology department

Prof. Thomas W Kraus has performed over 3,000 surgical interventions, specializing in complex stomach and pancreatic cancers. He leads the Nordwest Clinic's surgical department in Frankfurt.

• of experience in gastrointestinal oncology
• Founder and Director of the German Society 'Art of Surgery'
• Nationally recognized specialist in pancreatic surgery
• Trained at world-leading cancer centers in USA, France, and Japan
• Member of FACS and recipient of multiple surgical awards

Ezgi Sevic specializes in nutrition for cancer patients and has conducted research on chronic diseases and obesity during her studies at Hacettepe University.

• Graduated as an Honor Student from Hacettepe University
• Conducted studies on 'The Relationship Between Insulin Resistance and Obesity'
• Trained in post-metabolic and bariatric surgery nutrition
• Fluent in advanced English

Dr. Kariv specializes in laparoscopic and colorectal surgery, bringing precision and expertise to stomach cancer treatment.

• Focused on minimally invasive techniques for better patient outcomes
• Specialist in colorectal surgery, ensuring comprehensive care
• Practices at Assuta Medical Center, known for advanced oncology treatments

Dr. Zalmanova specializes in radiotherapy for stomach cancer at Assuta Medical Center.

• Radiotherapist with a focus on stomach cancer treatment
• Works at Assuta Medical Center, a leading healthcare facility
• Dedicated to personalized treatment plans for each patient

Dr. Gutman specializes in stomach cancer surgery at Assuta Medical Center.

• Experienced oncosurgeon with a focus on gastrointestinal cancers
• Works at Assuta Medical Center – a leading oncology facility
• Dedicated to personalized treatment plans for each patient

Dr. Alexander Beny is the Director of Gastrointestinal Malignant Service at Rambam Medical Center, overseeing a dedicated clinic for stomach cancer.

• He has advanced training from ESTRO in modern Brachytherapy Techniques.
• He completed his extensive residency in Medical and Radiation Oncology at Rambam.
• His work focuses on the Gastro-Intestinal Oncology clinic.
• He is certified by the European Community and Israeli Boards in Medicine.

Deputy Head of the Department of Oncology at Rambam Medical Center – a leading role in treating stomach cancer.

• Specializes in gastrointestinal oncology
• Works at one of Israel's top medical centers
• Focuses on advanced treatment approaches